| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 20 | 2025 | 740 | 1.820 |
Why?
|
| Adenocarcinoma | 9 | 2025 | 972 | 0.980 |
Why?
|
| Sequence Analysis, DNA | 7 | 2021 | 1692 | 0.740 |
Why?
|
| Genome, Human | 9 | 2025 | 1321 | 0.730 |
Why?
|
| Transplants | 1 | 2021 | 38 | 0.670 |
Why?
|
| Mutation | 14 | 2026 | 6099 | 0.640 |
Why?
|
| Biomarkers, Tumor | 7 | 2025 | 1586 | 0.640 |
Why?
|
| Organ Transplantation | 1 | 2021 | 175 | 0.570 |
Why?
|
| Receptors, Somatostatin | 4 | 2011 | 55 | 0.570 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2025 | 196 | 0.570 |
Why?
|
| Ampulla of Vater | 3 | 2025 | 15 | 0.560 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 210 | 0.560 |
Why?
|
| Gene Library | 2 | 2025 | 212 | 0.500 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 27 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2016 | 58 | 0.460 |
Why?
|
| Common Bile Duct Neoplasms | 2 | 2025 | 10 | 0.450 |
Why?
|
| Cholangiocarcinoma | 3 | 2023 | 126 | 0.430 |
Why?
|
| Bile Duct Neoplasms | 3 | 2023 | 130 | 0.430 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 223 | 0.420 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 2 | 2016 | 18 | 0.420 |
Why?
|
| Gene Expression Profiling | 5 | 2015 | 1801 | 0.390 |
Why?
|
| DNA-Binding Proteins | 5 | 2026 | 1939 | 0.360 |
Why?
|
| Genomics | 7 | 2025 | 1621 | 0.340 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2014 | 982 | 0.300 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2015 | 170 | 0.290 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 48 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2020 | 2026 | 0.290 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2021 | 37 | 0.290 |
Why?
|
| Liver Neoplasms | 5 | 2017 | 1373 | 0.290 |
Why?
|
| Transcription Factors | 4 | 2017 | 2406 | 0.280 |
Why?
|
| Genetic Techniques | 1 | 2009 | 95 | 0.280 |
Why?
|
| Genetic Testing | 3 | 2026 | 1106 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2011 | 2833 | 0.270 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2026 | 629 | 0.270 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2022 | 67 | 0.260 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 252 | 0.260 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2020 | 484 | 0.260 |
Why?
|
| Tissue Banks | 3 | 2011 | 27 | 0.250 |
Why?
|
| Humans | 57 | 2026 | 131163 | 0.240 |
Why?
|
| Base Sequence | 9 | 2017 | 2730 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2026 | 3436 | 0.230 |
Why?
|
| Homeodomain Proteins | 5 | 2016 | 555 | 0.230 |
Why?
|
| Neoplasm Proteins | 4 | 2009 | 680 | 0.230 |
Why?
|
| RNA, Messenger | 11 | 2017 | 2550 | 0.230 |
Why?
|
| Trans-Activators | 5 | 2016 | 697 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2015 | 597 | 0.220 |
Why?
|
| Strepsirhini | 1 | 2025 | 2 | 0.220 |
Why?
|
| Intellectual Disability | 3 | 2022 | 1089 | 0.220 |
Why?
|
| Precision Medicine | 3 | 2015 | 388 | 0.220 |
Why?
|
| Integrins | 5 | 2016 | 89 | 0.220 |
Why?
|
| Cell Line, Tumor | 12 | 2025 | 3748 | 0.210 |
Why?
|
| Antigens, CD | 3 | 2001 | 410 | 0.210 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 3464 | 0.210 |
Why?
|
| Mosaicism | 1 | 2026 | 248 | 0.200 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 775 | 0.200 |
Why?
|
| U937 Cells | 2 | 2001 | 22 | 0.200 |
Why?
|
| Gene Flow | 1 | 2023 | 13 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2025 | 526 | 0.200 |
Why?
|
| Receptors, Cell Surface | 4 | 2009 | 420 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 7 | 2012 | 1447 | 0.200 |
Why?
|
| Papio | 1 | 2023 | 58 | 0.190 |
Why?
|
| Membrane Glycoproteins | 3 | 2009 | 405 | 0.190 |
Why?
|
| Monocytes | 2 | 2002 | 335 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2002 | 544 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2025 | 407 | 0.190 |
Why?
|
| Genes, Neoplasm | 2 | 2016 | 80 | 0.180 |
Why?
|
| Databases, Genetic | 3 | 2016 | 504 | 0.180 |
Why?
|
| Neoplasms | 3 | 2016 | 3016 | 0.180 |
Why?
|
| Lung Neoplasms | 7 | 2015 | 1545 | 0.180 |
Why?
|
| Biological Evolution | 1 | 2023 | 222 | 0.180 |
Why?
|
| Proteomics | 1 | 2006 | 615 | 0.180 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 71 | 0.180 |
Why?
|
| Receptors, IgE | 1 | 2001 | 11 | 0.170 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 159 | 0.170 |
Why?
|
| Antigens, CD20 | 1 | 2001 | 44 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 357 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2023 | 234 | 0.170 |
Why?
|
| Genotype | 3 | 2011 | 2595 | 0.170 |
Why?
|
| Cell Movement | 4 | 2020 | 876 | 0.170 |
Why?
|
| INDEL Mutation | 1 | 2021 | 93 | 0.170 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 126 | 0.170 |
Why?
|
| Glioblastoma | 2 | 1995 | 371 | 0.170 |
Why?
|
| Prognosis | 5 | 2025 | 4886 | 0.170 |
Why?
|
| Cardiovascular Diseases | 2 | 2026 | 2121 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 509 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2026 | 781 | 0.160 |
Why?
|
| DNA, Neoplasm | 2 | 2016 | 282 | 0.160 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 34 | 0.150 |
Why?
|
| Genes, Dominant | 1 | 2020 | 242 | 0.150 |
Why?
|
| Animals | 30 | 2025 | 33912 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 3 | 1995 | 223 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 388 | 0.150 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2016 | 26 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2021 | 235 | 0.150 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2005 | 895 | 0.150 |
Why?
|
| Transfection | 7 | 2010 | 962 | 0.140 |
Why?
|
| Patient Selection | 2 | 2020 | 729 | 0.140 |
Why?
|
| DNA Methylation | 3 | 2021 | 1077 | 0.140 |
Why?
|
| Male | 20 | 2026 | 64957 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 229 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2020 | 440 | 0.140 |
Why?
|
| Abnormalities, Multiple | 2 | 2022 | 963 | 0.140 |
Why?
|
| Endothelium, Vascular | 3 | 1997 | 468 | 0.130 |
Why?
|
| Biopsy | 1 | 2021 | 1239 | 0.130 |
Why?
|
| Tissue Donors | 1 | 2021 | 506 | 0.130 |
Why?
|
| Phenotype | 7 | 2026 | 4497 | 0.130 |
Why?
|
| Female | 17 | 2026 | 70963 | 0.130 |
Why?
|
| Mice | 21 | 2016 | 18301 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 2395 | 0.120 |
Why?
|
| Adenovirus E3 Proteins | 1 | 1996 | 3 | 0.120 |
Why?
|
| Islets of Langerhans | 3 | 2012 | 163 | 0.120 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 79 | 0.120 |
Why?
|
| Cardiology | 1 | 2021 | 514 | 0.120 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2015 | 5 | 0.120 |
Why?
|
| Osmoregulation | 1 | 2015 | 2 | 0.120 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 96 | 0.120 |
Why?
|
| Integrin alpha5beta1 | 1 | 2015 | 4 | 0.120 |
Why?
|
| DNA, Complementary | 2 | 2009 | 422 | 0.120 |
Why?
|
| Caenorhabditis elegans | 2 | 2015 | 251 | 0.120 |
Why?
|
| Glycogen | 1 | 2015 | 50 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 73 | 0.110 |
Why?
|
| Cell Line | 6 | 2014 | 2552 | 0.110 |
Why?
|
| Brain Neoplasms | 2 | 1995 | 1306 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 757 | 0.110 |
Why?
|
| Macrophages | 1 | 2000 | 667 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 889 | 0.110 |
Why?
|
| Gene Expression | 1 | 2000 | 1481 | 0.110 |
Why?
|
| Microsatellite Repeats | 1 | 2016 | 204 | 0.110 |
Why?
|
| Adult | 7 | 2026 | 31282 | 0.110 |
Why?
|
| Endosomes | 1 | 2015 | 70 | 0.110 |
Why?
|
| Neutrophils | 1 | 1997 | 371 | 0.110 |
Why?
|
| Gluconeogenesis | 1 | 2015 | 93 | 0.110 |
Why?
|
| Middle Aged | 6 | 2026 | 28601 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2015 | 173 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 1995 | 110 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2009 | 623 | 0.110 |
Why?
|
| Oncogenes | 4 | 2010 | 164 | 0.110 |
Why?
|
| Cell Proliferation | 7 | 2023 | 2465 | 0.110 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 266 | 0.110 |
Why?
|
| Estrone | 1 | 2014 | 11 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2026 | 6797 | 0.100 |
Why?
|
| Fibrosarcoma | 3 | 1990 | 21 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2016 | 245 | 0.100 |
Why?
|
| Alleles | 2 | 2026 | 1673 | 0.100 |
Why?
|
| Spermatozoa | 1 | 1996 | 254 | 0.100 |
Why?
|
| Whole Genome Sequencing | 2 | 2026 | 362 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 992 | 0.100 |
Why?
|
| Membrane Proteins | 4 | 2020 | 1590 | 0.100 |
Why?
|
| RNA Interference | 2 | 2012 | 491 | 0.100 |
Why?
|
| Genes, ras | 2 | 1990 | 95 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 4 | 2020 | 631 | 0.090 |
Why?
|
| Insulinoma | 1 | 2012 | 8 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 1996 | 892 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2014 | 200 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 386 | 0.090 |
Why?
|
| Pedigree | 3 | 2025 | 1677 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2012 | 176 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 60 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2003 | 295 | 0.090 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2011 | 41 | 0.090 |
Why?
|
| Glucose | 3 | 2023 | 853 | 0.090 |
Why?
|
| Young Adult | 2 | 2026 | 10103 | 0.080 |
Why?
|
| Histone Acetyltransferases | 1 | 2012 | 226 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 1205 | 0.080 |
Why?
|
| Neoplasm Metastasis | 3 | 1990 | 713 | 0.080 |
Why?
|
| Somatostatin | 1 | 2011 | 60 | 0.080 |
Why?
|
| Autophagy | 1 | 2014 | 417 | 0.080 |
Why?
|
| DNA | 1 | 1996 | 1399 | 0.080 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 70 | 0.080 |
Why?
|
| Patient Care | 1 | 2011 | 98 | 0.080 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 1996 | 155 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 198 | 0.080 |
Why?
|
| Epigenomics | 3 | 2021 | 181 | 0.080 |
Why?
|
| Aged | 5 | 2026 | 21025 | 0.080 |
Why?
|
| Dystonic Disorders | 1 | 2011 | 92 | 0.080 |
Why?
|
| Genome | 1 | 2012 | 451 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2001 | 2885 | 0.080 |
Why?
|
| Endopeptidases | 1 | 1990 | 106 | 0.080 |
Why?
|
| Urogenital Abnormalities | 1 | 2012 | 155 | 0.080 |
Why?
|
| Axons | 1 | 2012 | 386 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2014 | 587 | 0.070 |
Why?
|
| DNA Primers | 2 | 2003 | 599 | 0.070 |
Why?
|
| Inteins | 1 | 2009 | 3 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2014 | 791 | 0.070 |
Why?
|
| Cytokines | 1 | 1995 | 1339 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2002 | 1928 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 53 | 0.070 |
Why?
|
| Adolescent | 4 | 2026 | 20987 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 1990 | 232 | 0.070 |
Why?
|
| Catalysis | 1 | 2009 | 136 | 0.070 |
Why?
|
| Risk | 1 | 2011 | 726 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 69 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 277 | 0.070 |
Why?
|
| ras Proteins | 1 | 2009 | 140 | 0.070 |
Why?
|
| Kinetics | 2 | 2009 | 1088 | 0.070 |
Why?
|
| Nuclear Proteins | 3 | 2020 | 1211 | 0.070 |
Why?
|
| Pharmacogenetics | 2 | 2021 | 201 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 1410 | 0.060 |
Why?
|
| Exons | 1 | 2009 | 759 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 1591 | 0.060 |
Why?
|
| Liver | 6 | 2017 | 1796 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2010 | 825 | 0.060 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 533 | 0.060 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2025 | 20 | 0.060 |
Why?
|
| Mitochondria | 3 | 2017 | 785 | 0.060 |
Why?
|
| Neoplasm Transplantation | 3 | 2012 | 358 | 0.060 |
Why?
|
| Smoking | 1 | 2011 | 932 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2005 | 70 | 0.060 |
Why?
|
| Papio anubis | 1 | 2025 | 4 | 0.060 |
Why?
|
| Madagascar | 1 | 2025 | 8 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2012 | 585 | 0.060 |
Why?
|
| Apoptosis | 3 | 2014 | 1827 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1826 | 0.050 |
Why?
|
| alpha-Fetoproteins | 4 | 1988 | 125 | 0.050 |
Why?
|
| Mutation Rate | 1 | 2025 | 68 | 0.050 |
Why?
|
| Haplotypes | 1 | 2026 | 519 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2016 | 700 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2025 | 387 | 0.050 |
Why?
|
| Signal Transduction | 4 | 2015 | 4686 | 0.050 |
Why?
|
| Exome | 3 | 2014 | 1061 | 0.050 |
Why?
|
| Subtraction Technique | 1 | 2003 | 36 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2017 | 429 | 0.050 |
Why?
|
| Baclofen | 1 | 2023 | 44 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2023 | 60 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 125 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2016 | 336 | 0.050 |
Why?
|
| Texas | 2 | 2026 | 3686 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2023 | 103 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2003 | 3359 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 21 | 0.050 |
Why?
|
| Integrin beta1 | 3 | 1997 | 51 | 0.050 |
Why?
|
| Species Specificity | 1 | 2023 | 470 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 42 | 0.050 |
Why?
|
| Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2002 | 2 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 197 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 521 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2022 | 87 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 110 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2021 | 38 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 780 | 0.040 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 47 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2002 | 92 | 0.040 |
Why?
|
| Acetyltransferases | 2 | 2000 | 75 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 975 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2023 | 323 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 2 | 2011 | 70 | 0.040 |
Why?
|
| Leukemia, Myeloid | 1 | 2001 | 80 | 0.040 |
Why?
|
| Phylogeny | 1 | 2023 | 689 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 358 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 54 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 4738 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2021 | 240 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 274 | 0.040 |
Why?
|
| Independent Living | 1 | 2020 | 64 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 156 | 0.040 |
Why?
|
| Mediator Complex | 1 | 2020 | 62 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2002 | 337 | 0.040 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2000 | 53 | 0.040 |
Why?
|
| Forecasting | 2 | 2011 | 351 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 203 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2000 | 97 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2000 | 234 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2016 | 722 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 17753 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 1207 | 0.040 |
Why?
|
| Pancreas | 2 | 2012 | 217 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2002 | 579 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2026 | 887 | 0.040 |
Why?
|
| Protein Transport | 2 | 2015 | 366 | 0.040 |
Why?
|
| United States | 4 | 2021 | 12072 | 0.040 |
Why?
|
| Leukemia | 1 | 2002 | 387 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 621 | 0.030 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 2 | 1995 | 13 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 1998 | 46 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1996 | 125 | 0.030 |
Why?
|
| Running | 1 | 1998 | 32 | 0.030 |
Why?
|
| Acute Disease | 1 | 2001 | 1153 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2000 | 307 | 0.030 |
Why?
|
| Reference Values | 2 | 1998 | 676 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 619 | 0.030 |
Why?
|
| Integrin alpha6beta1 | 1 | 1997 | 2 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1997 | 6 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 1997 | 27 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 664 | 0.030 |
Why?
|
| Family | 1 | 2020 | 589 | 0.030 |
Why?
|
| DNA Glycosylases | 1 | 2017 | 26 | 0.030 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2017 | 37 | 0.030 |
Why?
|
| Plasmids | 2 | 1996 | 449 | 0.030 |
Why?
|
| Insulin | 2 | 2012 | 1149 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2017 | 65 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 1363 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 1997 | 200 | 0.030 |
Why?
|
| Salmon | 1 | 1996 | 5 | 0.030 |
Why?
|
| Hemizygote | 1 | 2016 | 13 | 0.030 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1996 | 30 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2016 | 4 | 0.030 |
Why?
|
| Thymidine Kinase | 1 | 1996 | 90 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 121 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1996 | 25 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2016 | 29 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 252 | 0.030 |
Why?
|
| Phosphoenolpyruvate | 1 | 2015 | 2 | 0.030 |
Why?
|
| Glycogen Phosphorylase | 1 | 2015 | 1 | 0.030 |
Why?
|
| Glycogen Synthase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Prolactin | 1 | 1996 | 142 | 0.030 |
Why?
|
| Access to Information | 1 | 2016 | 46 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 90 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 2015 | 35 | 0.030 |
Why?
|
| Proteins | 2 | 2012 | 1006 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2015 | 148 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 152 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2015 | 43 | 0.030 |
Why?
|
| Th2 Cells | 1 | 1996 | 188 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2026 | 1459 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 72 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 330 | 0.030 |
Why?
|
| Telomere | 1 | 2017 | 219 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2085 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1995 | 17 | 0.030 |
Why?
|
| CD58 Antigens | 1 | 1995 | 7 | 0.030 |
Why?
|
| Cricetinae | 1 | 2015 | 362 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2304 | 0.030 |
Why?
|
| Dexamethasone | 3 | 1988 | 250 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 118 | 0.030 |
Why?
|
| Disease Progression | 2 | 2011 | 2200 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 1995 | 64 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 188 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 161 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2016 | 133 | 0.030 |
Why?
|
| Child | 3 | 2026 | 26341 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 437 | 0.030 |
Why?
|
| Genes | 2 | 1988 | 308 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1996 | 686 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 373 | 0.030 |
Why?
|
| Birt-Hogg-Dube Syndrome | 1 | 2014 | 4 | 0.030 |
Why?
|
| Gene Expression Regulation | 3 | 1988 | 2323 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 161 | 0.030 |
Why?
|
| Glutamine | 1 | 2015 | 200 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 218 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 573 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 151 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 43 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 1075 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 258 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2014 | 165 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 826 | 0.030 |
Why?
|
| Telomerase | 1 | 2014 | 154 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 133 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 3819 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2016 | 194 | 0.020 |
Why?
|
| Chromatin | 1 | 2017 | 499 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 318 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 571 | 0.020 |
Why?
|
| CpG Islands | 1 | 2014 | 337 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 373 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 265 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1995 | 633 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2014 | 273 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 587 | 0.020 |
Why?
|
| Risk Factors | 2 | 2005 | 11074 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 119 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1483 | 0.020 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2012 | 16 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 483 | 0.020 |
Why?
|
| Blepharophimosis | 1 | 2012 | 25 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2012 | 59 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1988 | 65 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 198 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 978 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 981 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1652 | 0.020 |
Why?
|
| Metabolomics | 1 | 2015 | 501 | 0.020 |
Why?
|
| Bone Diseases, Developmental | 1 | 2012 | 64 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1029 | 0.020 |
Why?
|
| Glioma | 1 | 1996 | 494 | 0.020 |
Why?
|
| Codon | 1 | 2011 | 93 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 116 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2011 | 46 | 0.020 |
Why?
|
| Blepharoptosis | 1 | 2012 | 67 | 0.020 |
Why?
|
| Levodopa | 1 | 2011 | 92 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2012 | 435 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 129 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 224 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 821 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1995 | 993 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1071 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1013 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 729 | 0.020 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2009 | 15 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 737 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2009 | 20 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2009 | 21 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 804 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1988 | 17 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 1103 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 116 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2020 | 15110 | 0.020 |
Why?
|
| Growth Substances | 1 | 1988 | 99 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 2904 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 410 | 0.020 |
Why?
|
| Confidentiality | 1 | 2009 | 108 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1988 | 44 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2009 | 146 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 594 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2010 | 801 | 0.020 |
Why?
|
| Cerebellum | 1 | 2012 | 441 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 227 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 255 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1680 | 0.020 |
Why?
|
| Fibroblasts | 2 | 1988 | 849 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 645 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1990 | 451 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1988 | 263 | 0.020 |
Why?
|
| Informed Consent | 1 | 2009 | 351 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1996 | 37 | 0.010 |
Why?
|
| Lymphokines | 2 | 1996 | 62 | 0.010 |
Why?
|
| Decision Making | 1 | 2011 | 726 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 981 | 0.010 |
Why?
|
| Fetus | 1 | 1988 | 568 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1987 | 355 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 1272 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 903 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1833 | 0.010 |
Why?
|
| Computational Biology | 1 | 2009 | 862 | 0.010 |
Why?
|
| Hormones | 1 | 1983 | 162 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 109 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 2701 | 0.010 |
Why?
|
| Cell Size | 1 | 2002 | 77 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 4697 | 0.010 |
Why?
|
| Prednisolone | 1 | 1981 | 74 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 142 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 1489 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 292 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 341 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 335 | 0.010 |
Why?
|
| Transcriptional Activation | 2 | 1995 | 419 | 0.010 |
Why?
|
| Time Factors | 1 | 1990 | 6196 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1889 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 450 | 0.010 |
Why?
|
| Rats | 4 | 1988 | 3370 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 688 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1990 | 95 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1998 | 61 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 1571 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 135 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 1371 | 0.010 |
Why?
|
| Lewis X Antigen | 1 | 1996 | 11 | 0.010 |
Why?
|
| L-Selectin | 1 | 1996 | 18 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 33 | 0.010 |
Why?
|
| Albumins | 2 | 1988 | 87 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12936 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 1998 | 480 | 0.010 |
Why?
|
| Integrin alpha1beta1 | 1 | 1994 | 3 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1995 | 332 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 235 | 0.010 |
Why?
|
| DNA Replication | 2 | 1988 | 355 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1990 | 159 | 0.000 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1990 | 111 | 0.000 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1988 | 40 | 0.000 |
Why?
|
| Cell Fusion | 1 | 1988 | 32 | 0.000 |
Why?
|
| Tyrosine Transaminase | 1 | 1988 | 7 | 0.000 |
Why?
|
| Epidermal Growth Factor | 1 | 1988 | 115 | 0.000 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1988 | 61 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1990 | 312 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1988 | 92 | 0.000 |
Why?
|
| Cytosol | 1 | 1988 | 135 | 0.000 |
Why?
|
| Fibroblast Growth Factors | 1 | 1988 | 172 | 0.000 |
Why?
|
| Lung | 1 | 1994 | 1535 | 0.000 |
Why?
|
| Medroxyprogesterone | 1 | 1983 | 9 | 0.000 |
Why?
|
| Methionine | 1 | 1983 | 95 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1981 | 181 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1981 | 101 | 0.000 |
Why?
|